Skip to content

Clinical trials

Completed Atherosclerosis trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20091
20102
20112
20122
20131
20141
20151
20162
20181
20201
20213
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Amgen1
AstraZeneca1
CSL Behring1
Eli Lilly and Company1
Esperion Therapeutics, Inc.1
Eximo Medical Ltd.1
Humacyte, Inc.1
Ionis Pharmaceuticals, Inc.1
Maria Sklodowska-Curie National Research Institute of Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis23
Cardiovascular Diseases5
Coronary Artery Disease5
Coronary Disease4
Peripheral Arterial Disease4
Heart Diseases3
Hypercholesterolemia3
Acute Coronary Syndrome2
Dyslipidemias2
Inflammation2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.